[Abstract Only] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
3 Jun, 2019 | 07:31h | UTCApalutamide for Metastatic, Castration-Sensitive Prostate Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentaries: Adding Apalutamide to ADT Prolongs Survival in mCSPC – Renal & Urology News (free) AND TITAN: OS benefit seen with apalutamide in metastatic CSPC setting – Medicine Matters (free)